Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin

Abstract Mirabegron and tamsulosin have recently been prescribed to men with overactive bladder for the treatment of benign prostatic hypertrophy. An efficient and environmentally friendly HPLC method was developed to accurately measure the levels of mirabegron and tamsulosin in both their pure form...

Full description

Saved in:
Bibliographic Details
Main Authors: Eman A. Bahgat, Hanaa Saleh, Islam M. Darwish, Omar M El-Abassy
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-89216-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850172393023078400
author Eman A. Bahgat
Hanaa Saleh
Islam M. Darwish
Omar M El-Abassy
author_facet Eman A. Bahgat
Hanaa Saleh
Islam M. Darwish
Omar M El-Abassy
author_sort Eman A. Bahgat
collection DOAJ
description Abstract Mirabegron and tamsulosin have recently been prescribed to men with overactive bladder for the treatment of benign prostatic hypertrophy. An efficient and environmentally friendly HPLC method was developed to accurately measure the levels of mirabegron and tamsulosin in both their pure form and in medication formulations. Full separation was achieved on an X-Bridge C18 column using a gradient elution of (The A mobile phase was a buffer solution containing 1 mL of trifluoroacetic acid and 3 mL of triethylamine in 1,000 milliliters of water, the pH of the solution was then adjusted to 3 using triethylamine and the B-mobile phase was acetonitrile). The chromatographic peaks were obtained at a wavelength of 220 nm. Mirabegron and tamsulosin were identified with retention time values of 2.4 min and 8.9 min, respectively. In the concentration ranges of 2.5–55 µg/mL for mirabegron and 5–110 µg/mL for tamsulosin, remarkable linearity was seen. The limits of detection for the two analytes were 0.28 and 0.55 µg/mL, respectively, and their R2 values were 0.9999. The new HPLC method was evaluated for its environmental friendliness using the Analytical GREEness (AGREE) metric. Furthermore, the suggested technique was considered practicable based on the evaluation conducted using the Blue Applicability Grade Index (BAGI) assessment. Both evaluation methods were quite successful, yielding scores of 0.52 and 80, respectively. Compared to the TLC-reported method, HPLC is the preferred choice for the separation of the two analytes due to its sensitivity.
format Article
id doaj-art-4c70b5b650cf4deda917cfa11f3de035
institution OA Journals
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-4c70b5b650cf4deda917cfa11f3de0352025-08-20T02:20:06ZengNature PortfolioScientific Reports2045-23222025-02-0115111010.1038/s41598-025-89216-5Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and TamsulosinEman A. Bahgat0Hanaa Saleh1Islam M. Darwish2Omar M El-Abassy3Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Zagazig UniversityPharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Zagazig UniversityEgyptian Drug AuthorityPharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian Russian UniversityAbstract Mirabegron and tamsulosin have recently been prescribed to men with overactive bladder for the treatment of benign prostatic hypertrophy. An efficient and environmentally friendly HPLC method was developed to accurately measure the levels of mirabegron and tamsulosin in both their pure form and in medication formulations. Full separation was achieved on an X-Bridge C18 column using a gradient elution of (The A mobile phase was a buffer solution containing 1 mL of trifluoroacetic acid and 3 mL of triethylamine in 1,000 milliliters of water, the pH of the solution was then adjusted to 3 using triethylamine and the B-mobile phase was acetonitrile). The chromatographic peaks were obtained at a wavelength of 220 nm. Mirabegron and tamsulosin were identified with retention time values of 2.4 min and 8.9 min, respectively. In the concentration ranges of 2.5–55 µg/mL for mirabegron and 5–110 µg/mL for tamsulosin, remarkable linearity was seen. The limits of detection for the two analytes were 0.28 and 0.55 µg/mL, respectively, and their R2 values were 0.9999. The new HPLC method was evaluated for its environmental friendliness using the Analytical GREEness (AGREE) metric. Furthermore, the suggested technique was considered practicable based on the evaluation conducted using the Blue Applicability Grade Index (BAGI) assessment. Both evaluation methods were quite successful, yielding scores of 0.52 and 80, respectively. Compared to the TLC-reported method, HPLC is the preferred choice for the separation of the two analytes due to its sensitivity.https://doi.org/10.1038/s41598-025-89216-5MirabegronTamsulosinHPLCAGREEBAGIInterval plot
spellingShingle Eman A. Bahgat
Hanaa Saleh
Islam M. Darwish
Omar M El-Abassy
Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin
Scientific Reports
Mirabegron
Tamsulosin
HPLC
AGREE
BAGI
Interval plot
title Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin
title_full Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin
title_fullStr Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin
title_full_unstemmed Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin
title_short Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin
title_sort green hplc technique development for the simultaneous determination of the potential combination of mirabegron and tamsulosin
topic Mirabegron
Tamsulosin
HPLC
AGREE
BAGI
Interval plot
url https://doi.org/10.1038/s41598-025-89216-5
work_keys_str_mv AT emanabahgat greenhplctechniquedevelopmentforthesimultaneousdeterminationofthepotentialcombinationofmirabegronandtamsulosin
AT hanaasaleh greenhplctechniquedevelopmentforthesimultaneousdeterminationofthepotentialcombinationofmirabegronandtamsulosin
AT islammdarwish greenhplctechniquedevelopmentforthesimultaneousdeterminationofthepotentialcombinationofmirabegronandtamsulosin
AT omarmelabassy greenhplctechniquedevelopmentforthesimultaneousdeterminationofthepotentialcombinationofmirabegronandtamsulosin